Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine

Françoise Derouane(Cliniques Universitaires Saint-Luc), François P. Duhoux(Cliniques Universitaires Saint-Luc)

Cancers

August 11, 2022

10.3390/cancers14163876

Cited by 89

Related Papers

Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers

|Breast Cancer Research|2024|23